Johnson and Johnson asked to cut down price of new TB drug

​​ To ensure the drug is accessible to all, MSF called on J&J to issue a non-exclusive license to the Medicines Patent Pool to allow for price-lowering competition among generic producers.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news